PIK3CA Pathway Mutations Predictive of Poor Response Following Standard Radiochemotherapy ± Cetuximab in Cervical Cancer Patients
暂无分享，去创建一个
P. Petrow | I. Bièche | B. Weber | T. Petit | V. Bernard | A. Floquet | D. Berton‐Rigaud | F. Joly | M. Kamal | P. Beuzeboc | L. Gladieff | S. Scholl | M. Fabbro | C. Kerr | C. Plancher | S. Maillard | H. Curé | E. Sevin | L. Gonzague | M. Minsat | A. de la Rochefordière | V. Fourchotte | K. Peignaux | Alhassane Diallo | M. Pop | L. Thomas | Q. Leroy | M. Aumont | A. Margogne | B. Asselain | Sébastien Armanet | C. Brunaud | A. Nadan | D. Berton-Rigaud